PIRAMAL PHARMA
|
PIRAMAL PHARMA Last 5 Year Cashflow Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|
Profit Before Tax | ₹120 Cr | ₹-161 Cr | ₹441 Cr | ₹884 Cr |
Adjustment | ₹1,276 Cr | ₹1,136 Cr | ₹787 Cr | ₹478 Cr |
Changes In working Capital | ₹-234 Cr | ₹-302 Cr | ₹-292 Cr | ₹-620 Cr |
Cash Flow after changes in Working Capital | ₹1,161 Cr | ₹673 Cr | ₹936 Cr | ₹742 Cr |
Cash Flow from Operating Activities | ₹1,005 Cr | ₹484 Cr | ₹766 Cr | ₹598 Cr |
Cash Flow from Investing Activities | ₹-434 Cr | ₹-1,339 Cr | ₹-1,812 Cr | ₹-4,480 Cr |
Cash Flow from Financing Activities | ₹-422 Cr | ₹818 Cr | ₹794 Cr | ₹3,977 Cr |
Net Cash Inflow / Outflow | ₹148 Cr | ₹-37 Cr | ₹-251 Cr | ₹94 Cr |
Opening Cash & Cash Equivalents | ₹53 Cr | ₹85 Cr | ₹262 Cr | ₹152 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | ₹77 Cr | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | ₹11 Cr |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - |
Effect of Foreign Exchange Fluctuations | ₹18 Cr | ₹5.15 Cr | ₹-2.04 Cr | ₹4.22 Cr |
Closing Cash & Cash Equivalent | ₹219 Cr | ₹53 Cr | ₹85 Cr | ₹262 Cr |
Compare Cashflow Statement of peers of PIRAMAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PIRAMAL PHARMA | ₹28,039.5 Cr | 3.6% | 1.5% | 42.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,519.0 Cr | 1.6% | -2.9% | 17.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,903.0 Cr | 1.5% | 10.4% | 51.9% | Stock Analytics | |
CIPLA | ₹121,669.0 Cr | 2.3% | 1.9% | 2.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,097.0 Cr | 5.7% | 14.1% | 15.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,605.0 Cr | 1.4% | 1.3% | 17% | Stock Analytics |
PIRAMAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PIRAMAL PHARMA | 3.6% |
1.5% |
42.7% |
SENSEX | 1.3% |
2.6% |
7.8% |
You may also like the below Video Courses